Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00KGI
|
|||
| Former ID |
DIB012784
|
|||
| Drug Name |
IVN-201
|
|||
| Indication | Allergy [ICD-11: 4A80-4A85; ICD-10: T78.4; ICD-9: 995.3] | Phase 1 | [1] | |
| Company |
ImVisioN Therapeutics Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00718679) Evaluation of Safety, Tolerability, Immunogenicity and Efficacy of a Novel Method in Specific Immunotherapy in Cat Allergic Patients: a Placebo Controlled Trial. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.